Ecleralimab
Based on 1 Customer Validation
Ecleralimab (CSJ-117; NVP-CSJ117) is a Fab-IgG1-λ2 antibody targeting the thymic stromal lymphopoietin (TSLP). Ecleralimab significantly attenuates allergen-induced airway responses and inflammation. Ecleralimab can be used for the study of inhaled asthma.
For research use only. We do not sell to patients.
- Purity: 97.35%
- CAS No.: 2415207-91-7
- Molecular Weight:46.62 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Fab-G1-lambda2
Human
TSLP
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Q969D9-1
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Fab-G1-lambda2
ELISA, FACS, Functional assay
-
Immobilized TSLP Protein, Human can bind Ecleralimab. The EC50 for this effect is 17.78 ng/mL.
Chemical Information
-
CAS No. 2415207-91-7
-
Appearance Liquid
-
Molecular Weight 46.62 kDa
-
Color Colorless to light yellow
-
SMILES
[Ecleralimab]
-
Synonyms
CSJ-117; NVP-CSJ117
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)